Table 1.
Type of In Vitro Model | Application | Reference |
---|---|---|
Parallel-plate flow chamber with endothelial cells matrix-covered surface | Compare various low-molecular-weight heparin and a pentasaccharide for suitability in the in vitro thrombosis model | [43] |
Parallel-plate flow chamber-based model with fibrin- or fibrinogen-coated surface | Compare and characterize platelet adhesion to fibrin- and fibrinogen-coated surfaces under controlled flow | [26] |
Parallel-plate flow chamber-based model with collagen- or plaque-coated surface | Compare the thrombogenic effect of different collagen fibers to atherosclerotic plaque | [30] |
Flow chamber-based model with fibrinogen- or vWF-coated surface | Identify the mechanism of platelet adhesion to fibrinogen and vWF | [27] |
Flow chamber-based model with collagen-coated surface | Identify the role of human collagen receptors GPVI and α2β1 in thrombus formation |
[29] |
Fibrinogen-coated flow chambers | Assess platelet adhesion and aggregation following incubation with H2-rich saline | [44] |
Microfluidic-based device with blood flow under pathophysiological shear rate |
Measurement of coagulation and platelet function | [34] |
Microfluidic-based device with collagen-coated glass substrate | Measurement of platelet adhesion and blood viscosity | [35] |
Microfluidic lung chip device lined with primary human alveolar epithelium | Monitor pulmonary thrombosis development and evaluate the effect of different pro-thrombotic and anti-thrombotic factors | [45] |
Microfluidic device mimicking human venous valves | Develop a venous valvular stasis model and study the effect of platelets and red blood cells on thrombus development | [39] |
Occlusive thrombosis-on-a-chip microfluidic device | Evaluation of anti-thrombotic drugs | [33] |
Collagen-coated capillary with controlled rheological conditions | Examine the role of thrombin in platelet recruitment and thrombus stabilization | [46] |
Collagen-coated glass stenosis model | Describe the structure of arterial thrombi | [47] |
Endothelialized microfluidic device | Study the mechanism of FeCl3-induced thrombosis | [48] |
Endothelialized microfluidic device | Study the effect of microplastics on thrombus properties | [49] |
Endothelialized microfluidic device | A bioassay for hematological disorders and evaluating drug efficacy | [32] |
In vitro human plasma clot formation assay |
Compare the effect of aprotinin and tranexamic acid on the coagulation pathway and thrombus formation | [50] |
3D-bioprinted thrombosis on a chip model coated with human endothelium embedded in a hydrogel | Develop a highly human biomimetic thrombosis model and study its pathophysiology and potential drug efficacy assessment | [51] |
3D-printed microfluidic chip coated with human umbilical vein endothelial cells | Recapitulate the three-dimensional structure of healthy and stenotic coronary arteries and assess platelet aggregation | [52] |
Annular and rectangular perfusion chambers with steady flow | Study the effect of endothelial cells activation on thrombus formation | [53] |
Multiplate aggregometer and platelet function analyzer (PFA-100) | Test platelet aggregation to investigate cilostazol’s anti-platelet effect | [54] |
Blood-shearing device | Study the influence of non-physiological stress on platelets and vWF | [42] |